Androgen Reduction in Congenital Adrenal Hyperplasia

NCT03548246 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped This study plan has halted and was withdrawn from the IRB.

Conditions

Congenital Adrenal Hyperplasia

Interventions

DRUG: Abiraterone acetate
DRUG: Placebo
DRUG: Hydrocortisone
DRUG: Fludrocortisone

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]